GET THE APP

Non-melanoma Skin Cancer Studies
..

Cancer Science & Therapy

ISSN: 1948-5956

Open Access

Commentary - (2022) Volume 14, Issue 4

Non-melanoma Skin Cancer Studies

Takahashi Kawachik*
*Correspondence: Takahashi Kawachik, Tochigi Dermatology Clinic, Tochigi, Japan, Email:
Tochigi Dermatology Clinic, Tochigi, Japan

Received: 08-Apr-2022, Manuscript No. jcst-22-65989; Editor assigned: 09-Apr-2022, Pre QC No. P-65989; Reviewed: 21-Apr-2022, QC No. Q-65989; Revised: 25-Apr-2022, Manuscript No. R-65989; Published: 30-Apr-2022 , DOI: 10.37421/1948-5956. 2022.14.525
Citation: Kawachika, Takahashi. “Non-melanoma Skin Cancer Studies.” J Cancer Sci Ther 14 (2022): 525.
Copyright: © 2022 Kawachika T. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Description

Non-melanoma skin cancer encompasses all skin cancers that aren't melanoma. Non-melanoma skin cancer encompasses a number of different forms of skin cancer, the most frequent of which are basal cell carcinoma and squamous cell carcinoma. Treatment for non-melanoma skin cancer is determined by the type of malignancy. The most common therapy for skin cancer is surgery to remove the cancerous cells. Angiosarcoma is a type of cancer that develops in the lining of blood and lymph arteries. The immune system includes lymph vessels. The lymph vessels gather and dispose of bacteria, viruses, and waste materials from the body. This type of cancer can strike at any time and in any part of the body. However, it happens the majority of the time [1].

Angiosarcoma develops when the DNA of cells in the lining of a blood artery or lymph channel changes. The DNA of a cell includes the instructions that tell it what to do. Doctors call these changes mutations, and they tell the cells to reproduce quickly. When healthy cells die, the alterations cause the cells to continue to live. As a result, cancer cells accumulate and can spread beyond the blood stream or lymph channel. Cancer cells have the ability to penetrate and kill healthy human tissue. Cancer cells may break free and spread to other parts of the body over time [2].

Radiation therapy for cancer or other illnesses can raise the risk of developing angiosarcoma. Angiosarcoma is an uncommon adverse effect of radiation therapy. Lymphedema is swelling produced by a back-up of lymph fluid. When the lymphatic system becomes clogged or injured, this occurs. When lymph nodes are removed during surgery, lymphedema can result. This is frequently done during cancer surgery. Lymphedema can also occur as a result of an infection or other medical disorders. Several substances have been related to liver angiosarcoma. Vinyl chloride and arsenic are two examples of these compounds. Angiosarcoma is caused by certain gene mutations that can be passed down from generation to generation. Gene alterations that cause neurofibromatosis, Maffucci syndrome, or Klippel-Trenaunay syndrome, as well as the BRCA1 and BRCA2 genes, are examples [3].

Non-melanoma Skin Cancer (NMSC) is the most frequent type of skin cancer among Caucasians, but it also affects people of other races. Basal Cell (BCC) and Squamous Cell (SCC) carcinomas, as well as other less common kinds of cutaneous cancer, make up the majority of NMSC. NMSC is caused by UV radiation, which causes keratinocytes to become malignant. Skin cancers that aren't melanoma (basal and squamous cell carcinomas) are the most frequent, albeit they're rarely lethal. Melanoma of the skin is uncommon in black people, but it is becoming more common in white people in many regions of the world. Based on information from studies of atomic bomb survivors and radiologists, ionising radiation is a well-recognized cause of non-melanoma skin cancer [4].

Skin cancer that develops in the squamous cells that make up the middle and outer layers of the skin is known as squamous cell carcinoma. Skin cancer called squamous cell carcinoma is normally not life-threatening, but it can be aggressive. Squamous cell carcinoma of the skin, if left untreated, can become large and spread to other parts of the body, posing major health risks. The majority of skin squamous cell carcinomas are caused by extended exposure to Ultraviolet (UV) radiation, which can come from the sun, tanning beds, or lamps. Squamous cell carcinoma of the skin and other types of skin cancer can be reduced by avoiding UV exposure [5].

Merkel cell carcinoma is a rare type of skin cancer that usually appears as a flesh-colored or bluish-red nodule, often on your face, head or neck. Merkel cell carcinoma is also called neuroendocrine carcinoma of the skin. Merkel cell carcinoma most often develops in older people. Long-term sun exposure or a weak immune system may increase your risk of developing Merkel cell carcinoma. Merkel cell carcinoma tends to grow fast and to spread quickly to other parts of your body. Treatment options for Merkel cell carcinoma often depend on whether the cancer has spread beyond the skin.

Conflict of Interest

None.

References

  1. Liu, Ruolin, Qianyi Wan, Rui Zhao and Haitao Xiao, et al. "Risk of non-melanoma skin cancer with biological therapy in common inflammatory diseases: a systemic review and meta-analysis." Cancer Cell Int 21 (2021): 1-17.
  2. Indexed at, Google Scholar, Crossref

  3. Shalhout, Sophia Z, Kevin S. Emerick, Howard L. Kaufman and David M. Miller. "Immunotherapy for non-melanoma skin cancer." Curr Oncol Rep 23 (2021): 1-10.
  4. Indexed at, Google Scholar, Crossref

  5. Trager, Megan H., Larisa J. Geskin, Faramarz H. Samie and Liang Liu. "Biomarkers in melanoma and non‐melanoma skin cancer prevention and risk stratification." Exp Dermatol 31 (2022): 4-12.
  6. Indexed at, Google Scholar, Crossref

  7. Souto, Eliana B., Raquel Da Ana, Vânia Vieira and Joana F. Fangueiro, et al. "Non-melanoma skin cancers: Physio-pathology and role of lipid delivery systems in new chemotherapeutic treatments." Neoplasia 30 (2022): 100810.
  8. Indexed at, Google Scholar, Crossref

  9. Zelin, Enrico, Iris Zalaudek, Marina Agozzino and Caterina Dianzani, et al. "Neoadjuvant therapy for non-melanoma skin cancer: Updated therapeutic approaches for basal, squamous, and merkel cell carcinoma." Current Treatm Opt Oncol 22 (2021): 1-24.
  10. Indexed at, Google Scholar, Crossref

Google Scholar citation report
Citations: 3968

Cancer Science & Therapy received 3968 citations as per Google Scholar report

Cancer Science & Therapy peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward